Key result
LGE-assessed myocardial fibrosis in NSTEMI culprit regions decreases ~33% over six to ten months.
Why the study?
CMR imaging allows tracking of ongoing fibrosis modifications after MI, prompting an evaluation of temporal changes in LGE and ECV in culprit and remote myocardial regions after NSTEMI.
Does myocardial fibrosis assessed by CMR LGE and ECV change over time following type 1 NSTEMI?
Observational (n=30)
No
Does myocardial fibrosis assessed by CMR LGE and ECV change over time following type 1 NSTEMI?
Absolute Event Rate: 9.5% vs 14.2%
p-value: p=0.015
In patients with NSTEMI, myocardial fibrosis assessed by LGE decreases over 6-10 months in the culprit territory, whereas ECV remains unchanged.
Supports LGE fibrosis regression as hypothesis-generating post-NSTEMI; leaves open prognostic value and need for randomized confirmation.
Introduction Cardiac magnetic resonance (CMR) imaging allows tracking of ongoing fibrosis modifications following myocardial infarction (MI). We evaluated temporal changes in late gadolinium enhancement (LGE) and extracellular volume fraction (ECV) within the MI culprit coronary artery and remote regions of the myocardium during the index ischemic event and follow-up in patients with NSTEMI. Methods This prospective, single-center study included 30 patients with type 1 NSTEMI. It involved the evaluation of patients using coronary angiography, invasive coronary physiology, and biomarkers. CMR imaging was used to assess left ventricular (LV) volume, function, and myocardial fibrosis using LGE and ECV. These assessments were performed at baseline and repeated 6-10 months after MI. Results At the 4-year post-MI follow-up, 27 patients survived [age 65 (58,74) years; 77% male], and LV mass, volume, and contractility remained unchanged between the baseline and follow-up measurements. Myocardial fibrosis assessed using LGE showed a decreasing trend at follow-up (9.4 ± 4.4% vs. 6.7 ± 4.4%; p = 0.051), particularly in the MI culprit coronary artery regions (14.2 ± 8.6% vs. 9.5 ± 7.0%; p = 0.015). LGE volume regression was observed in 70% of cases. The ECV measurements did not change between the initial and follow-up CMR assessments. Despite the high prevalence of multivessel coronary artery disease (CAD) (53%), no significant changes in LGE or ECV measurements were observed in the remote myocardium. Conclusions After NSTEMI, LGE decreased in the heart regions supplied by the culprit coronary arteries. However, the ECV measurements remained unchanged. Multivessel CAD was not associated with significant changes in myocardial fibrosis in the remote myocardium.
No takes yet. Share an insight, caveat, or question.
Paiva et al. (2025) conducted an observational in non-ST-segment elevation myocardial infarction (NSTEMI) (n=30). Cardiac magnetic resonance (CMR) imaging vs. Baseline was evaluated on Late gadolinium enhancement (LGE) in MI culprit coronary artery regions (p=0.015). In patients with NSTEMI, myocardial fibrosis assessed by late gadolinium enhancement significantly decreased in the culprit coronary artery regions from 14.2% at baseline to 9.5% at 6-10 months follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: